Filing Flows › Comparisons › PACB vs QTRX
Pacific Biosciences of California vs Quanterix: PACB and QTRX compared
Pacific Biosciences of California is the larger company: $40.6M of revenue in its latest quarter (Q3 2026) against $32.9M for Quanterix (Q2 2026). Quanterix is growing faster (+34% against +6% a year earlier). Pacific Biosciences of California is more profitable, with an operating margin of -91.2% against -150.2%.
Where the money goes: PACB and QTRX
Pacific Biosciences of California (PACB) · Q3 2026
Pacific Biosciences of California, Q3 2026: revenue $40.6M (+6% year over year), operating margin -91.2%, net loss $37.8M, operating cash flow −$37.6M. The chart follows the revenue to costs, profit and cash.
Quanterix (QTRX) · Q2 2026
Quanterix, Q2 2026: revenue $32.9M (+34% year over year), operating margin -150.2%, net loss $48.9M, operating cash flow −$5.1M. The chart follows the revenue to costs, profit and cash.
| Pacific Biosciences of California (PACB) | Quanterix (QTRX) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q2 2026 |
| Revenue | $40.6M | $32.9M |
| Revenue growth, Y/Y | +6% | +34% |
| Operating margin | -91.2% | -150.2% |
| Net earnings | −$37.8M | −$48.9M |
| Net margin | -93.3% | -148.7% |
| Operating cash flow | −$37.6M | −$5.1M |
| Market value | — | $147M |
| Analysts’ mean target | — | $3.17 |
Where the revenue comes from
Pacific Biosciences of California
- Product revenue: $34.0M (84%)
- Service and other revenue: $6.6M (16%)
Quanterix
- Product revenue: $23.4M (71%)
- Spatial biology: $9.3M (28%)
Questions
Which is bigger, Pacific Biosciences of California or Quanterix?
Pacific Biosciences of California is the larger company: $40.6M of revenue in its latest quarter (Q3 2026) against $32.9M for Quanterix (Q2 2026).
Is Pacific Biosciences of California or Quanterix growing faster?
Quanterix is growing faster (+34% against +6% a year earlier).
Which is more profitable, Pacific Biosciences of California or Quanterix?
Pacific Biosciences of California is more profitable, with an operating margin of -91.2% against -150.2%.
More: Pacific Biosciences of California earnings · how Pacific Biosciences of California makes money · Quanterix earnings · how Quanterix makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 5, 2026; 10-Q filed Aug 10, 2026). Fiscal quarters can end on different dates. Not investment advice.